Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/S0140-6736(15)00108-7 | DOI Listing |
Lancet Rheumatol
January 2025
Infectious Diseases, Asante Three Rivers Medical Center, Grants Pass, OR, USA.
Lancet Diabetes Endocrinol
January 2025
Division of Diabetes & Nutritional Sciences, School of Cardiovascular and Metabolic Medicine & Sciences, King's College London, London, UK; Catholic University of the Sacred Heart, Rome, Italy; University Polyclinic Foundation Agostino Gemelli IRCCS, Rome, Italy.
Lancet Diabetes Endocrinol
January 2025
Centre for Endocrinology and Metabolism, Hudson Institute of Medical Research, Clayton, VIC, Australia; Department of Endocrinology, Monash Health, Clayton, VIC, Australia.
Background: Primary aldosteronism can be treated medically but there is no standardised method to evaluate treatment outcomes. We aimed to develop criteria for assessing the outcomes of targeted medical treatment of primary aldosteronism, analyse outcomes across an international cohort, and identify factors associated with a complete treatment response.
Methods: An international panel of 31 primary aldosteronism experts used the Delphi method to reach consensus on the definition of complete, partial, or absent biochemical and clinical outcomes of medical treatment of primary aldosteronism.
Lancet Diabetes Endocrinol
January 2025
Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique (IPLESP), Réseau Sentinelles, Paris, France; Department of Internal Medicine, Tenon Hospital, Assistance Publique-Hôpitaux de Paris, Paris F-75020, France. Electronic address:
Lancet Glob Health
January 2025
Department of Community Medicine, ESI-PGIMSR, Medical College & Hospital, Kolkata, West Bengal, India.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!